Regulus Therapeutics Inc. (RGLS) NASDAQ

$2.20 0.07 (3.29%)

Market Cap: $139.44M

As of 04/22/24 04:00 PM EDT. Market closed.

(RGLS)

Regulus Therapeutics Inc. (RGLS)
NASDAQ

$2.20
0.07 (3.29%)

Market Cap: $139.44M

As of 04/22/24 04:00 PM EDT. Market closed.

Add to Portfolio

regulus therapeutics inc. (nasdaq:rgls) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting micrornas. regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microrna therapeutics pipeline complemented by a maturing micromarkerssm biomarkers platform and a rich intellectual property estate to ... read more

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Hagan
Full Time Employees
47
CEO Compensation (Base)
$475,300
CEO Compensation (Total)
$1.92M
URL
Address
10628 Science Center Dr Ste 225, California, San Diego, 92121-1124.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Joseph Hagan
Full Time Employees
47
CEO Compensation (Base)
$475,300
CEO Compensation (Total)
$1.92M
Address
10628 Science Center Dr Ste 225, California, San Diego, 92121-1124.
PRICE CHART FOR REGULUS THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.14
Previous Close
$2.13
Days Range
$2.09 - $2.31
52 week range
$1.08 - $3.79
Volume
127,753
Avg. Volume (30 days)
450,684
Market Cap
$139.44M
Dividend Yield
-
P/E
-
Shares Outstanding
65,465,251
Open
$2.14
Previous Close
$2.13
Days Range
$2.09 - $2.31
52 week range
$1.08 - $3.79
Volume
127,753
Avg. Volume (30 days)
450,684
Market Cap
$139.44M
Dividend Yield
-
P/E
-
Shares Outstanding
65,465,251
FINANCIAL STATEMENTS FOR REGULUS THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR REGULUS THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
PAPADOPOULOS STELIOSDirectorMar 14, 2024 Option Exercise$1.60250,000400,000978,388Mar 15, 2024, 04:19 PM
CALSADA CRISPINAChief Financial OfficerJan 18, 2024 Sale$1.195,4686,5105,782Jan 18, 2024, 08:24 PM
Aker Christopher RaySr. VP & General CounselJan 18, 2024 Sale$1.195,4686,51010,056Jan 18, 2024, 08:23 PM
Hagan Joseph PChief Executive OfficerJan 18, 2024 Sale$1.1914,58017,35957,112Jan 18, 2024, 08:22 PM
PAPADOPOULOS STELIOSDirectorApr 13, 2023 Option Exercise$0.90222,198200,000728,388Apr 14, 2023, 04:39 PM
Drygin DenisChief Scientific OfficerMar 01, 2022 Buy$0.2376,68617,638100,000Mar 01, 2022, 05:58 PM
Drygin DenisChief Scientific OfficerFeb 04, 2022 Buy$0.2323,3145,36223,314Feb 07, 2022, 05:09 PM
Hagan Joseph PPresident and CEOJan 26, 2022 Buy$0.22100,00021,520417,006Jan 26, 2022, 04:13 PM
PAPADOPOULOS STELIOSDirectorNov 30, 2021 Option Exercise$0.362,222,222800,0005,061,929Dec 01, 2021, 04:12 PM
Aker Christopher RaySr. VP & General CounselMay 17, 2021 Sale$0.8986076541,754May 17, 2021, 07:12 PM
Hagan Joseph PPresident and CEOFeb 16, 2021 Sale$1.724,1447,128244,628Apr 16, 2021, 04:11 PM
Aker Christopher RaySr. VP & General CounselFeb 16, 2021 Sale$1.728281,42442,614Feb 17, 2021, 05:23 PM
Hagan Joseph PPresident and CEOFeb 16, 2021 Sale$1.724,1447,128485,756Feb 17, 2021, 05:23 PM
PAPADOPOULOS STELIOSDirectorDec 04, 2020 Option Exercise$0.63793,528500,0022,839,707Jan 27, 2021, 08:16 PM
Walker Paul Edward10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:14 PM
Sonsini Peter W.10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:13 PM
SANDELL SCOTT D10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:12 PM
MAKOWER JOSHUA10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:12 PM
Makhzoumi Mohamad10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:11 PM
Florence Anthony A. Jr.10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:10 PM
Chang Carmen10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:10 PM
Behbahani Ali10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:09 PM
BASKETT FOREST10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:08 PM
Growth Equity Opportunities V, LLC10% OwnerDec 04, 2020 Buy$0.624,398,6022,735,9306,451,056Dec 07, 2020, 05:06 PM
Hagan Joseph PPresident and CEODec 04, 2020 Option Exercise$0.6339,68025,002225,674Dec 07, 2020, 04:22 PM
PAPADOPOULOS STELIOSDirectorDec 04, 2020 Option Exercise$0.63793,528500,0021,986,729Dec 07, 2020, 04:21 PM
Aker Christopher RaySr. VP & General CounselNov 16, 2020 Sale$0.5287645625,762Nov 18, 2020, 04:10 PM
Hagan Joseph PPresident and CEONov 16, 2020 Sale$0.526,0943,176215,994Nov 18, 2020, 04:09 PM
Hagan Joseph PPresident and CEOAug 14, 2020 Sale$0.604,2452,568222,088Aug 17, 2020, 08:22 PM
Aker Christopher RaySr. VP & General CounselAug 14, 2020 Sale$0.6187252826,638Aug 17, 2020, 08:21 PM
Hagan Joseph PPresident and CEOMay 15, 2020 Sale$0.634,4262,774226,333May 18, 2020, 04:28 PM
Aker Christopher RaySr. VP & General CounselMay 15, 2020 Sale$0.6390957027,510May 18, 2020, 04:27 PM
Hagan Joseph PPresident and CEOFeb 18, 2020 Sale$0.834,3243,591230,759Feb 19, 2020, 06:09 PM
Aker Christopher RaySr. VP & General CounselFeb 18, 2020 Sale$0.8388873728,419Feb 19, 2020, 06:08 PM
Hagan Joseph PPresident and CEOJan 02, 2020 Sale$0.978,3458,067235,083Jan 03, 2020, 04:07 PM
Aker Christopher RaySr. VP & General CounselJan 02, 2020 Sale$0.972,2392,16429,307Jan 03, 2020, 04:06 PM
Aker Christopher RaySr. VP & General CounselNov 14, 2019 Sale$0.6483353331,546Nov 15, 2019, 05:37 PM
Hagan Joseph PPresident and CEONov 14, 2019 Sale$0.645,8383,736243,428Nov 15, 2019, 05:36 PM
Aker Christopher RaySr. VP & General CounselOct 01, 2019 Sale$0.682,3461,60232,379Oct 02, 2019, 06:50 PM
Hagan Joseph PPresident and CEOOct 01, 2019 Sale$0.688,7435,969249,266Oct 02, 2019, 06:17 PM
Hagan Joseph PPresident and CEOAug 15, 2019 Sale$0.554,3752,409258,009Aug 16, 2019, 04:17 PM
Aker Christopher RaySr. VP & General CounselAug 15, 2019 Sale$0.5589949534,725Aug 16, 2019, 04:16 PM
Hagan Joseph PPresident and CEOJul 01, 2019 Sale$1.315,7837,584262,384Jul 02, 2019, 05:42 PM
Aker Christopher RaySr. VP & General CounselJul 01, 2019 Sale$1.312,2252,91835,624Jul 02, 2019, 05:42 PM
Chevallard Daniel R.Chief Financial OfficerJul 01, 2019 Sale$1.312,6693,50077,870Jul 02, 2019, 05:41 PM
PAPADOPOULOS STELIOSDirectorMay 07, 2019 Option Exercise$1.08370,370400,0001,189,872May 21, 2019, 04:46 PM
RASTETTER WILLIAM HDirectorMay 07, 2019 Option Exercise$1.0892,889100,320154,223May 21, 2019, 04:45 PM
Witz PascaleDirectorMay 07, 2019 Option Exercise$1.0829,63032,00037,849May 21, 2019, 04:44 PM
Hagan Joseph PPresident and CEOMay 07, 2019 Option Exercise$1.0833,19435,85064,542May 21, 2019, 04:42 PM
Hagan Joseph PPresident and CEOMay 16, 2019 Sale$1.2239,35247,966268,167May 16, 2019, 05:25 PM
Chevallard Daniel R.Chief Financial OfficerMay 15, 2019 Sale$1.4110,00014,08980,539May 16, 2019, 05:21 PM
Aker Christopher RaySr. VP & General CounselMay 15, 2019 Sale$1.416,9509,79659,309May 16, 2019, 05:21 PM
Walker Paul Edward10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 10, 2019, 10:59 AM
Walker Paul EdwardDirectorMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:08 PM
Sonsini Peter W.10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:07 PM
SANDELL SCOTT D10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:07 PM
MOTT DAVID M10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:06 PM
MAKOWER JOSHUA10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:06 PM
Makhzoumi Mohamad10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:05 PM
Florence Anthony A. Jr.10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:05 PM
Chang Carmen10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:05 PM
Behbahani Ali10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:04 PM
BASKETT FOREST10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:04 PM
BARRIS PETER J10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:02 PM
Growth Equity Opportunities V, LLC10% OwnerMay 07, 2019 Buy$1.081,136,7041,227,6402,052,454May 09, 2019, 06:02 PM
Hagan Joseph PPresident and CEOMay 07, 2019 Buy$1.0833,19435,85064,542May 08, 2019, 05:15 PM
Witz PascaleDirectorMay 07, 2019 Buy$1.0829,63032,00037,849May 08, 2019, 05:15 PM
RASTETTER WILLIAM HDirectorMay 07, 2019 Buy$1.0892,889100,320154,223May 08, 2019, 05:14 PM
PAPADOPOULOS STELIOSDirectorMay 07, 2019 Buy$1.08370,370400,0001,189,872May 08, 2019, 05:13 PM
Hagan Joseph PPresident and CEOApr 01, 2019 Sale$0.985,8425,73131,348Apr 03, 2019, 04:31 PM
Aker Christopher RaySr. VP & General CounselApr 01, 2019 Sale$0.982,7102,6596,287Apr 03, 2019, 04:15 PM
Chevallard Daniel R.Chief Financial OfficerApr 01, 2019 Sale$0.983,2533,1929,372Apr 03, 2019, 12:00 AM
WRIGHT TIMOTHY MICHAELChief R & D OfficerFeb 05, 2019 Option Exercise$0.9540,00038,00062,893Feb 06, 2019, 04:52 PM
Hagan Joseph PPresident and CEOFeb 05, 2019 Option Exercise$0.9565,00061,75084,148Feb 06, 2019, 04:51 PM
Chevallard Daniel R.Chief Financial OfficerFeb 05, 2019 Option Exercise$0.9530,00028,50034,578Feb 06, 2019, 04:50 PM
PAPADOPOULOS STELIOSDirectorDec 28, 2018 Buy$1.0950,00054,570835,073Jan 02, 2019, 04:12 PM
PAPADOPOULOS STELIOSDirectorDec 27, 2018 Buy$1.0426,40127,460785,073Dec 28, 2018, 04:21 PM
PAPADOPOULOS STELIOSDirectorDec 26, 2018 Buy$0.9590,00085,878758,672Dec 28, 2018, 04:21 PM
PAPADOPOULOS STELIOSDirectorNov 16, 2018 Buy$1.38300,000415,470668,672Nov 19, 2018, 04:03 PM
PAPADOPOULOS STELIOSDirectorNov 15, 2018 Buy$1.33200,000265,080368,672Nov 19, 2018, 04:03 PM
Collier Kathryn JDirectorNov 16, 2018 Buy$1.417,10010,01127,596Nov 19, 2018, 04:01 PM
Collier Kathryn JDirectorJun 05, 2018 Option Exercise$0.747,6955,6947,695Jun 05, 2018, 04:28 PM
Collier Kathryn JDirectorApr 14, 2018 Option Exercise$0.6460,23438,55060,234Apr 17, 2018, 04:36 PM
BALTIMORE DAVIDDirectorDec 04, 2017 Option Exercise$0.8960,67454,00060,674Dec 06, 2017, 07:43 PM
FOLETTA MARK GDirectorDec 04, 2017 Option Exercise$0.8971,91064,00081,910Dec 06, 2017, 07:42 PM
PAPADOPOULOS STELIOSDirectorDec 04, 2017 Option Exercise$0.8996,62986,0001,797,306Dec 06, 2017, 07:41 PM
Rosen HughDirectorDec 04, 2017 Option Exercise$0.8956,17949,99956,179Dec 06, 2017, 07:40 PM
Witz PascaleDirectorDec 04, 2017 Option Exercise$0.8960,67454,00060,674Dec 06, 2017, 07:39 PM
RASTETTER WILLIAM HDirectorDec 04, 2017 Option Exercise$0.8969,66261,999694,387Dec 06, 2017, 07:38 PM
WRIGHT TIMOTHY MICHAELChief R & D OfficerJul 25, 2017 Buy$0.91274,725250,000274,725Jul 25, 2017, 06:09 PM
RASTETTER WILLIAM HDirectorJul 25, 2017 Buy$0.91274,725250,000624,625Jul 25, 2017, 06:09 PM
Hagan Joseph PPresident and CEOJul 25, 2017 Buy$0.91219,780200,000241,297Jul 25, 2017, 06:08 PM
Chevallard Daniel R.Chief Financial OfficerJul 25, 2017 Buy$0.9154,94550,00059,415Jul 25, 2017, 06:07 PM
PAPADOPOULOS STELIOSDirectorJul 25, 2017 Buy$0.911,000,000910,0001,770,677Jul 25, 2017, 06:06 PM
PAPADOPOULOS STELIOSDirectorMar 22, 2017 Buy$1.23300,000368,100700,677Mar 23, 2017, 04:26 PM
PAPADOPOULOS STELIOSDirectorMar 21, 2017 Buy$1.20200,000239,800400,677Mar 23, 2017, 04:26 PM
RASTETTER WILLIAM HDirectorMar 07, 2017 Buy$1.15250,000287,500350,000Mar 07, 2017, 04:59 PM
Hagan Joseph PChief Operating OfficerMar 03, 2016 Buy$7.1910,00071,90010,000Mar 07, 2016, 05:20 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerFeb 23, 2016 Sale$7.181,000,0007,180,0004,896,716Feb 24, 2016, 06:20 PM
FOLETTA MARK GDirectorAug 13, 2015 Buy$7.6410,00076,40510,000Aug 13, 2015, 06:10 PM
PAPADOPOULOS STELIOSDirectorAug 07, 2015 Option Exercise$1.5550,67778,801200,677Aug 07, 2015, 06:05 PM
RASTETTER WILLIAM HDirectorJul 21, 2015 Buy$10.1961,235624,199100,000Jul 21, 2015, 08:47 PM
RASTETTER WILLIAM HDirectorJul 20, 2015 Buy$10.1338,765392,77938,765Jul 21, 2015, 08:47 PM
ISIS PHARMACEUTICALS INC10% OwnerJul 15, 2015 Sale$10.7665,133700,9615,451,172Jul 17, 2015, 06:08 PM
ISIS PHARMACEUTICALS INC10% OwnerJul 17, 2015 Sale$10.21111,0001,133,7545,173,172Jul 17, 2015, 06:08 PM
ISIS PHARMACEUTICALS INC10% OwnerJul 16, 2015 Sale$10.79167,0001,801,3625,284,172Jul 17, 2015, 06:08 PM
ISIS PHARMACEUTICALS INC10% OwnerJun 30, 2015 Sale$10.7913,248143,0105,516,305Jul 02, 2015, 04:28 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOApr 21, 2015 Option Exercise$0.3860,00022,80063,705Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOApr 20, 2015 Option Exercise$0.3866,07125,10769,776Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOApr 17, 2015 Option Exercise$0.3873,92928,09377,634Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOApr 21, 2015 Sale$17.7360,0001,063,9803,705Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOApr 20, 2015 Sale$16.8566,0711,113,5143,705Apr 21, 2015, 07:06 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOApr 17, 2015 Sale$16.9473,9291,252,0023,705Apr 21, 2015, 07:06 PM
CARTER BRUCE L ADirectorApr 13, 2015 Option Exercise$4.7820,00095,60020,000Apr 14, 2015, 05:12 PM
CARTER BRUCE L ADirectorApr 13, 2015 Sale$17.6620,000353,1640Apr 14, 2015, 05:12 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOMar 05, 2015 Option Exercise$0.3889,23033,90791,696Mar 05, 2015, 07:17 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOMar 05, 2015 Sale$20.2689,2301,808,06326,082Mar 05, 2015, 07:17 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOFeb 27, 2015 Option Exercise$0.3870272,536Mar 03, 2015, 05:27 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOFeb 27, 2015 Sale$19.50701,3652,466Mar 03, 2015, 05:27 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOFeb 02, 2015 Option Exercise$0.382,4009124,866Feb 03, 2015, 05:39 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOJan 30, 2015 Option Exercise$0.383,3001,2545,766Feb 03, 2015, 05:39 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOJan 30, 2015 Sale$19.503,30064,3512,466Feb 03, 2015, 05:39 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOFeb 02, 2015 Sale$19.772,40047,4402,466Feb 03, 2015, 05:39 PM
Gibson Neil WChief Scientific OfficerJan 28, 2015 Sale$18.0580,0001,444,3048,655Jan 30, 2015, 05:45 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOJan 28, 2015 Option Exercise$0.3885,00032,30087,466Jan 30, 2015, 05:22 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOJan 29, 2015 Option Exercise$0.3860,00022,80062,466Jan 30, 2015, 05:22 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOJan 29, 2015 Sale$18.0460,0001,082,63428,693Jan 30, 2015, 05:22 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOJan 28, 2015 Sale$18.0885,0001,536,51515,455Jan 30, 2015, 05:22 PM
PAPADOPOULOS STELIOSDirectorDec 12, 2014 Option Exercise$0.38150,00057,000150,000Dec 15, 2014, 12:58 PM
Gibson Neil WChief Scientific OfficerNov 28, 2014 Option Exercise$1.742,5004,35082,500Dec 01, 2014, 04:49 PM
Gibson Neil WChief Scientific OfficerNov 28, 2014 Sale$19.302,50048,24581,500Dec 01, 2014, 04:49 PM
ASTRAZENECA PLC10% OwnerNov 12, 2014 Sale$17.002,000,00034,000,0004,250,000Nov 14, 2014, 04:05 PM
ISIS PHARMACEUTICALS INC10% OwnerNov 03, 2014 Sale$15.941,279,41120,390,6135,516,305Nov 05, 2014, 06:48 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 29, 2014 Option Exercise$0.383,5051,3325,971Oct 31, 2014, 04:52 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 29, 2014 Sale$19.353,50567,8244,571Oct 31, 2014, 04:52 PM
Gibson Neil WChief Scientific OfficerOct 29, 2014 Option Exercise$1.742,5004,35082,500Oct 31, 2014, 04:50 PM
Gibson Neil WChief Scientific OfficerOct 29, 2014 Sale$19.292,50048,23481,400Oct 31, 2014, 04:50 PM
ISIS PHARMACEUTICALS INCDirectorOct 22, 2014 Sale$14.00109,5341,533,1356,899,517Oct 28, 2014, 05:03 PM
ISIS PHARMACEUTICALS INCDirectorOct 24, 2014 Sale$15.191,85028,1096,796,512Oct 28, 2014, 05:03 PM
ISIS PHARMACEUTICALS INCDirectorOct 23, 2014 Sale$14.241,70024,2026,798,066Oct 28, 2014, 05:03 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 24, 2014 Sale$15.191,85028,1095,897,512Oct 28, 2014, 04:59 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 23, 2014 Sale$14.241,70024,2025,899,066Oct 28, 2014, 04:59 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 22, 2014 Sale$14.00109,5341,533,1356,000,517Oct 28, 2014, 04:59 PM
ISIS PHARMACEUTICALS INCDirectorOct 22, 2014 Sale$14.00109,5341,533,1266,799,266Oct 24, 2014, 09:29 PM
ISIS PHARMACEUTICALS INCDirectorOct 24, 2014 Sale$15.191,85028,1096,795,716Oct 24, 2014, 09:29 PM
ISIS PHARMACEUTICALS INCDirectorOct 23, 2014 Sale$14.241,70024,2026,797,566Oct 24, 2014, 09:29 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 24, 2014 Sale$15.191,85028,1095,896,716Oct 24, 2014, 09:27 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 23, 2014 Sale$14.241,70024,2025,898,566Oct 24, 2014, 09:27 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 22, 2014 Sale$14.00109,5341,533,1265,900,266Oct 24, 2014, 09:27 PM
Gibson Neil WChief Scientific OfficerOct 22, 2014 Option Exercise$1.743,3005,74283,300Oct 24, 2014, 04:16 PM
Gibson Neil WChief Scientific OfficerOct 22, 2014 Sale$14.443,30047,64480,000Oct 24, 2014, 04:16 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 20, 2014 Option Exercise$0.383001142,766Oct 21, 2014, 04:07 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 17, 2014 Option Exercise$0.384001522,866Oct 21, 2014, 04:07 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 20, 2014 Sale$7.003002,1002,466Oct 21, 2014, 04:07 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 17, 2014 Sale$7.044002,8162,466Oct 21, 2014, 04:07 PM
ISIS PHARMACEUTICALS INCDirectorOct 17, 2014 Sale$6.793,00020,3716,908,800Oct 17, 2014, 05:38 PM
ISIS PHARMACEUTICALS INCDirectorOct 16, 2014 Sale$6.764,80032,4506,911,800Oct 17, 2014, 05:38 PM
ISIS PHARMACEUTICALS INCDirectorOct 15, 2014 Sale$6.674,30028,6876,916,600Oct 17, 2014, 05:38 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 17, 2014 Sale$6.793,00020,3716,009,800Oct 17, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 16, 2014 Sale$6.764,80032,4506,012,800Oct 17, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 15, 2014 Sale$6.674,30028,6876,017,600Oct 17, 2014, 05:37 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 14, 2014 Option Exercise$0.384001522,866Oct 14, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 09, 2014 Option Exercise$0.38105402,571Oct 14, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 14, 2014 Sale$7.004002,8002,466Oct 14, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOOct 09, 2014 Sale$7.001057352,466Oct 14, 2014, 05:54 PM
ISIS PHARMACEUTICALS INCDirectorOct 10, 2014 Sale$6.412,00012,8136,920,900Oct 10, 2014, 06:26 PM
ISIS PHARMACEUTICALS INCDirectorOct 09, 2014 Sale$6.584,75031,2386,922,900Oct 10, 2014, 06:26 PM
ISIS PHARMACEUTICALS INCDirectorOct 08, 2014 Sale$6.633,30021,8886,927,650Oct 10, 2014, 06:26 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 10, 2014 Sale$6.412,00012,8136,021,900Oct 10, 2014, 06:25 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 09, 2014 Sale$6.584,75031,2386,023,900Oct 10, 2014, 06:25 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 08, 2014 Sale$6.633,30021,8886,028,650Oct 10, 2014, 06:25 PM
ISIS PHARMACEUTICALS INCDirectorOct 03, 2014 Sale$6.883,30022,6886,930,950Oct 03, 2014, 05:20 PM
ISIS PHARMACEUTICALS INCDirectorOct 02, 2014 Sale$6.643,75024,9036,934,250Oct 03, 2014, 05:20 PM
ISIS PHARMACEUTICALS INCDirectorOct 01, 2014 Sale$6.713,25021,8086,938,000Oct 03, 2014, 05:20 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 03, 2014 Sale$6.883,30022,6886,031,950Oct 03, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 02, 2014 Sale$6.643,75024,9036,035,250Oct 03, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerOct 01, 2014 Sale$6.713,25021,8086,039,000Oct 03, 2014, 05:19 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOSep 30, 2014 Option Exercise$0.382,3008744,766Oct 02, 2014, 07:17 PM
XANTHOPOULOS KLEANTHIS GPresident and CEOSep 30, 2014 Sale$7.022,30016,1372,466Oct 02, 2014, 07:17 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 25, 2014 Sale$7.122,50017,7906,044,750Sep 26, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 24, 2014 Sale$7.193,75026,9786,047,250Sep 26, 2014, 05:37 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 26, 2014 Sale$7.042,50017,5986,042,250Sep 26, 2014, 05:37 PM
ISIS PHARMACEUTICALS INCDirectorSep 26, 2014 Sale$7.042,50017,5986,941,250Sep 26, 2014, 05:36 PM
ISIS PHARMACEUTICALS INCDirectorSep 25, 2014 Sale$7.122,50017,7906,943,750Sep 26, 2014, 05:36 PM
ISIS PHARMACEUTICALS INCDirectorSep 24, 2014 Sale$7.193,75026,9786,946,250Sep 26, 2014, 05:36 PM
ISIS PHARMACEUTICALS INCDirectorSep 18, 2014 Sale$7.401,50011,0986,954,100Sep 19, 2014, 05:10 PM
ISIS PHARMACEUTICALS INCDirectorSep 17, 2014 Sale$7.432,10015,6106,955,600Sep 19, 2014, 05:10 PM
ISIS PHARMACEUTICALS INCDirectorSep 19, 2014 Sale$7.224,10029,5876,950,000Sep 19, 2014, 05:10 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 19, 2014 Sale$7.224,10029,5876,051,000Sep 19, 2014, 05:09 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 18, 2014 Sale$7.401,50011,0986,055,100Sep 19, 2014, 05:09 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 17, 2014 Sale$7.432,10015,6106,056,600Sep 19, 2014, 05:09 PM
Gibson Neil WChief Scientific OfficerSep 12, 2014 Option Exercise$1.742,2003,82882,200Sep 15, 2014, 05:14 PM
Gibson Neil WChief Scientific OfficerSep 11, 2014 Option Exercise$1.742,0003,48082,000Sep 15, 2014, 05:14 PM
Gibson Neil WChief Scientific OfficerSep 11, 2014 Sale$8.012,00016,01080,000Sep 15, 2014, 05:14 PM
Gibson Neil WChief Scientific OfficerSep 12, 2014 Sale$8.012,20017,61680,000Sep 15, 2014, 05:14 PM
ISIS PHARMACEUTICALS INCDirectorSep 12, 2014 Sale$7.963,50027,8616,957,700Sep 12, 2014, 06:26 PM
ISIS PHARMACEUTICALS INCDirectorSep 11, 2014 Sale$7.833,40026,6366,961,200Sep 12, 2014, 06:26 PM
ISIS PHARMACEUTICALS INCDirectorSep 10, 2014 Sale$7.702,00015,3996,964,600Sep 12, 2014, 06:26 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 12, 2014 Sale$7.963,50027,8616,058,700Sep 12, 2014, 06:24 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 11, 2014 Sale$7.833,40026,6366,062,200Sep 12, 2014, 06:24 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 10, 2014 Sale$7.702,00015,3996,065,600Sep 12, 2014, 06:24 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 04, 2014 Sale$7.116,00042,6566,070,000Sep 05, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 03, 2014 Sale$6.951,65011,4716,076,000Sep 05, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerSep 05, 2014 Sale$7.072,40016,9746,067,600Sep 05, 2014, 06:52 PM
ISIS PHARMACEUTICALS INCDirectorSep 05, 2014 Sale$7.072,40016,9746,966,600Sep 05, 2014, 05:57 PM
ISIS PHARMACEUTICALS INCDirectorSep 04, 2014 Sale$7.116,00042,6566,969,000Sep 05, 2014, 05:57 PM
ISIS PHARMACEUTICALS INCDirectorSep 03, 2014 Sale$6.951,65011,4716,975,000Sep 05, 2014, 05:57 PM
ISIS PHARMACEUTICALS INCDirectorAug 29, 2014 Sale$6.841,50010,2546,976,650Aug 29, 2014, 07:13 PM
ISIS PHARMACEUTICALS INCDirectorAug 28, 2014 Sale$6.962,00013,9216,978,150Aug 29, 2014, 07:13 PM
ISIS PHARMACEUTICALS INCDirectorAug 27, 2014 Sale$7.211,50010,8216,980,150Aug 29, 2014, 07:13 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 28, 2014 Sale$6.962,00013,9216,079,150Aug 29, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 27, 2014 Sale$7.211,50010,8216,081,150Aug 29, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 29, 2014 Sale$6.841,50010,2546,077,650Aug 29, 2014, 07:12 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOAug 28, 2014 Option Exercise$0.383,5051,3323,505Aug 29, 2014, 05:19 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOAug 28, 2014 Sale$7.063,50524,7540Aug 29, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 20, 2014 Sale$7.143,00021,4246,090,400Aug 22, 2014, 07:23 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 22, 2014 Sale$6.755,25035,4436,082,650Aug 22, 2014, 07:23 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 21, 2014 Sale$6.892,50017,2226,087,900Aug 22, 2014, 07:23 PM
ISIS PHARMACEUTICALS INCDirectorAug 22, 2014 Sale$6.755,25035,4436,981,650Aug 22, 2014, 07:22 PM
ISIS PHARMACEUTICALS INCDirectorAug 21, 2014 Sale$6.892,50017,2226,986,900Aug 22, 2014, 07:22 PM
ISIS PHARMACEUTICALS INCDirectorAug 20, 2014 Sale$7.143,00021,4246,989,400Aug 22, 2014, 07:22 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 15, 2014 Sale$6.981,45010,1156,093,400Aug 15, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 14, 2014 Sale$7.041,75012,3246,094,850Aug 15, 2014, 07:12 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 13, 2014 Sale$7.022,25015,7886,096,600Aug 15, 2014, 07:12 PM
ISIS PHARMACEUTICALS INCDirectorAug 15, 2014 Sale$6.981,45010,1156,992,400Aug 15, 2014, 07:11 PM
ISIS PHARMACEUTICALS INCDirectorAug 14, 2014 Sale$7.041,75012,3246,993,850Aug 15, 2014, 07:11 PM
ISIS PHARMACEUTICALS INCDirectorAug 13, 2014 Sale$7.022,25015,7886,995,600Aug 15, 2014, 07:11 PM
ISIS PHARMACEUTICALS INCDirectorAug 08, 2014 Sale$6.801,85012,5836,997,850Aug 08, 2014, 08:15 PM
ISIS PHARMACEUTICALS INCDirectorAug 07, 2014 Sale$6.662,60017,3226,999,700Aug 08, 2014, 08:15 PM
ISIS PHARMACEUTICALS INCDirectorAug 06, 2014 Sale$7.083,15022,3007,002,300Aug 08, 2014, 08:15 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 08, 2014 Sale$6.801,85012,5836,098,850Aug 08, 2014, 08:08 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 07, 2014 Sale$6.662,60017,3226,100,700Aug 08, 2014, 08:08 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 06, 2014 Sale$7.083,15022,3006,103,300Aug 08, 2014, 08:08 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOAug 05, 2014 Option Exercise$0.383,5051,3323,505Aug 07, 2014, 05:51 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOAug 05, 2014 Sale$7.063,50524,7390Aug 07, 2014, 05:51 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 30, 2014 Sale$6.601,0006,6026,110,800Aug 01, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerAug 01, 2014 Sale$6.212,60016,1536,106,450Aug 01, 2014, 06:52 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 31, 2014 Sale$6.421,75011,2356,109,050Aug 01, 2014, 06:52 PM
ISIS PHARMACEUTICALS INCDirectorAug 01, 2014 Sale$6.212,60016,1537,005,450Aug 01, 2014, 06:44 PM
ISIS PHARMACEUTICALS INCDirectorJul 31, 2014 Sale$6.421,75011,2357,008,050Aug 01, 2014, 06:44 PM
ISIS PHARMACEUTICALS INCDirectorJul 30, 2014 Sale$6.601,0006,6027,009,800Aug 01, 2014, 06:44 PM
ISIS PHARMACEUTICALS INCDirectorJul 25, 2014 Sale$6.551,70011,1377,010,800Jul 25, 2014, 08:41 PM
ISIS PHARMACEUTICALS INCDirectorJul 24, 2014 Sale$6.811,85012,5987,012,500Jul 25, 2014, 08:41 PM
ISIS PHARMACEUTICALS INCDirectorJul 23, 2014 Sale$6.881,70011,7027,014,350Jul 25, 2014, 08:41 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 23, 2014 Sale$6.881,70011,7026,115,350Jul 25, 2014, 08:40 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 25, 2014 Sale$6.551,70011,1376,111,800Jul 25, 2014, 08:40 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 24, 2014 Sale$6.811,85012,5986,113,500Jul 25, 2014, 08:40 PM
ISIS PHARMACEUTICALS INCDirectorJul 16, 2014 Sale$6.593,50023,0587,026,050Jul 18, 2014, 07:19 PM
ISIS PHARMACEUTICALS INCDirectorJul 18, 2014 Sale$6.805,00034,0017,016,050Jul 18, 2014, 07:19 PM
ISIS PHARMACEUTICALS INCDirectorJul 17, 2014 Sale$6.585,00032,9067,021,050Jul 18, 2014, 07:19 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 18, 2014 Sale$6.805,00034,0016,117,050Jul 18, 2014, 07:17 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 17, 2014 Sale$6.585,00032,9066,122,050Jul 18, 2014, 07:17 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 16, 2014 Sale$6.593,50023,0586,127,050Jul 18, 2014, 07:17 PM
ISIS PHARMACEUTICALS INCDirectorJul 11, 2014 Sale$6.481,75011,3397,029,550Jul 11, 2014, 08:25 PM
ISIS PHARMACEUTICALS INCDirectorJul 10, 2014 Sale$6.694,50030,1097,031,300Jul 11, 2014, 08:25 PM
ISIS PHARMACEUTICALS INCDirectorJul 09, 2014 Sale$7.081,80012,7487,035,800Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 11, 2014 Sale$6.481,75011,3396,130,550Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 10, 2014 Sale$6.694,50030,1096,132,300Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 09, 2014 Sale$7.081,80012,7486,136,800Jul 11, 2014, 08:25 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 03, 2014 Sale$8.071,2009,6786,138,600Jul 07, 2014, 05:19 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJul 02, 2014 Sale$8.073,10025,0116,139,800Jul 07, 2014, 05:19 PM
ISIS PHARMACEUTICALS INC10% OwnerJul 03, 2014 Sale$8.071,2009,6787,037,600Jul 07, 2014, 05:14 PM
ISIS PHARMACEUTICALS INC10% OwnerJul 02, 2014 Sale$8.073,10025,0117,038,800Jul 07, 2014, 05:14 PM
Gibson Neil WChief Scientific OfficerJul 01, 2014 Option Exercise$1.742,5004,35082,500Jul 02, 2014, 04:39 PM
Gibson Neil WChief Scientific OfficerJul 01, 2014 Sale$8.102,50020,26080,000Jul 02, 2014, 04:39 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOJul 01, 2014 Option Exercise$0.383,5051,3323,505Jul 02, 2014, 04:35 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOJul 01, 2014 Sale$8.113,50528,4260Jul 02, 2014, 04:35 PM
ISIS PHARMACEUTICALS INC10% OwnerJun 27, 2014 Sale$7.913,15024,9317,041,900Jun 27, 2014, 07:00 PM
ISIS PHARMACEUTICALS INC10% OwnerJun 26, 2014 Sale$7.891,70013,4087,045,050Jun 27, 2014, 07:00 PM
ISIS PHARMACEUTICALS INC10% OwnerJun 25, 2014 Sale$7.842,75021,5667,046,750Jun 27, 2014, 07:00 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJun 25, 2014 Sale$7.842,75021,5666,147,750Jun 27, 2014, 06:45 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJun 27, 2014 Sale$7.913,15024,9316,142,900Jun 27, 2014, 06:45 PM
ALNYLAM PHARMACEUTICALS, INC.10% OwnerJun 26, 2014 Sale$7.891,70013,4086,146,050Jun 27, 2014, 06:45 PM
Gibson Neil WChief Scientific OfficerJun 17, 2014 Option Exercise$1.745,0008,70085,000Jun 18, 2014, 05:54 PM
Gibson Neil WChief Scientific OfficerJun 17, 2014 Sale$8.055,00040,22780,000Jun 18, 2014, 05:54 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOJun 09, 2014 Option Exercise$0.383,5051,3323,505Jun 09, 2014, 07:31 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOJun 09, 2014 Sale$7.143,50525,0170Jun 09, 2014, 07:31 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMay 28, 2014 Option Exercise$0.38875332875May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMay 27, 2014 Option Exercise$0.381,7436621,743May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMay 29, 2014 Option Exercise$0.38887337887May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMay 28, 2014 Sale$7.008756,1260May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMay 27, 2014 Sale$7.001,74312,2030May 29, 2014, 07:57 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMay 29, 2014 Sale$7.008876,2090May 29, 2014, 07:57 PM
Gibson Neil WChief Scientific OfficerApr 09, 2014 Option Exercise$1.742,5004,35082,500Apr 10, 2014, 02:51 PM
Gibson Neil WChief Scientific OfficerApr 09, 2014 Sale$8.112,50020,27180,000Apr 10, 2014, 02:51 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMar 06, 2014 Option Exercise$0.383,5051,33283,721Apr 09, 2014, 02:02 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMar 06, 2014 Sale$7.603,50526,62380,216Apr 09, 2014, 02:02 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMar 06, 2014 Option Exercise$0.383,5051,33283,721Mar 07, 2014, 02:33 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOMar 06, 2014 Sale$11.353,50539,77880,216Mar 07, 2014, 02:33 PM
Gibson Neil WChief Scientific OfficerMar 06, 2014 Option Exercise$1.742,5004,35082,500Mar 07, 2014, 02:29 PM
Gibson Neil WChief Scientific OfficerMar 06, 2014 Sale$11.372,50028,42880,000Mar 07, 2014, 02:29 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOFeb 05, 2014 Option Exercise$0.383,5051,33283,721Feb 07, 2014, 03:09 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOFeb 05, 2014 Sale$8.403,50529,43780,216Feb 07, 2014, 03:09 PM
Gibson Neil WChief Scientific OfficerFeb 06, 2014 Option Exercise$1.7445,00078,30080,000Feb 07, 2014, 03:04 PM
Gibson Neil WChief Scientific OfficerFeb 05, 2014 Option Exercise$1.742,5004,35052,500Feb 07, 2014, 03:04 PM
Gibson Neil WChief Scientific OfficerFeb 05, 2014 Sale$8.3817,500146,70635,000Feb 07, 2014, 03:04 PM
Sanofi10% OwnerFeb 04, 2014 Buy$7.671,303,7809,999,9935,053,779Feb 05, 2014, 03:38 PM
Gibson Neil WChief Scientific OfficerJan 21, 2014 Option Exercise$2.664,42111,76054,421Jan 23, 2014, 02:33 PM
Gibson Neil WChief Scientific OfficerJan 21, 2014 Sale$8.094,42135,76450,000Jan 23, 2014, 02:33 PM
Gibson Neil WChief Scientific OfficerJan 17, 2014 Option Exercise$2.174,4799,70654,479Jan 21, 2014, 04:03 PM
Gibson Neil WChief Scientific OfficerJan 17, 2014 Sale$8.154,47936,49450,000Jan 21, 2014, 04:03 PM
Gibson Neil WChief Scientific OfficerJan 16, 2014 Option Exercise$1.741,1001,91451,100Jan 17, 2014, 01:35 PM
Gibson Neil WChief Scientific OfficerJan 16, 2014 Sale$8.031,1008,83750,000Jan 17, 2014, 01:35 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOJan 02, 2014 Option Exercise$0.383,5051,33283,721Jan 02, 2014, 08:52 PM
XANTHOPOULOS KLEANTHIS GPresident & CEOJan 02, 2014 Sale$7.253,50525,40880,216Jan 02, 2014, 08:52 PM
Gibson Neil WChief Scientific OfficerFeb 04, 2013 Option Exercise$1.7450,00087,00050,000Feb 14, 2013, 09:08 PM
ISIS PHARMACEUTICALS INC10% OwnerOct 10, 2012 Buy$4.00750,0003,000,0007,049,500Oct 11, 2012, 07:56 PM
PARSHALL B LYNNEDirectorOct 10, 2012 Buy$4.00750,0003,000,0007,049,500Oct 11, 2012, 07:53 PM
CROOKE STANLEY TDirectorOct 10, 2012 Buy$4.00750,0003,000,0007,049,500Oct 11, 2012, 07:52 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
PAPADOPOULOS STELIOSDirector03/14/2024400,000
CALSADA CRISPINAChief Financial Officer01/18/20246,510
Aker Christopher RaySr. VP & General Counsel01/18/20246,510
Hagan Joseph PChief Executive Officer01/18/202417,359
PAPADOPOULOS STELIOSDirector04/13/2023200,000
Drygin DenisChief Scientific Officer03/01/202217,638
Drygin DenisChief Scientific Officer02/04/20225,362
Hagan Joseph PPresident and CEO01/26/202221,520
PAPADOPOULOS STELIOSDirector11/30/2021800,000
Aker Christopher RaySr. VP & General Counsel05/17/2021765
Hagan Joseph PPresident and CEO02/16/20217,128
Aker Christopher RaySr. VP & General Counsel02/16/20211,424
Hagan Joseph PPresident and CEO02/16/20217,128
PAPADOPOULOS STELIOSDirector12/04/2020500,002
Walker Paul Edward10% Owner12/04/20202,735,930
Sonsini Peter W.10% Owner12/04/20202,735,930
SANDELL SCOTT D10% Owner12/04/20202,735,930
MAKOWER JOSHUA10% Owner12/04/20202,735,930
Makhzoumi Mohamad10% Owner12/04/20202,735,930
Florence Anthony A. Jr.10% Owner12/04/20202,735,930
Chang Carmen10% Owner12/04/20202,735,930
Behbahani Ali10% Owner12/04/20202,735,930
BASKETT FOREST10% Owner12/04/20202,735,930
Growth Equity Opportunities V, LLC10% Owner12/04/20202,735,930
Hagan Joseph PPresident and CEO12/04/202025,002
PAPADOPOULOS STELIOSDirector12/04/2020500,002
Aker Christopher RaySr. VP & General Counsel11/16/2020456
Hagan Joseph PPresident and CEO11/16/20203,176
Hagan Joseph PPresident and CEO08/14/20202,568
Aker Christopher RaySr. VP & General Counsel08/14/2020528
Hagan Joseph PPresident and CEO05/15/20202,774
Aker Christopher RaySr. VP & General Counsel05/15/2020570
Hagan Joseph PPresident and CEO02/18/20203,591
Aker Christopher RaySr. VP & General Counsel02/18/2020737
Hagan Joseph PPresident and CEO01/02/20208,067
Aker Christopher RaySr. VP & General Counsel01/02/20202,164
Aker Christopher RaySr. VP & General Counsel11/14/2019533
Hagan Joseph PPresident and CEO11/14/20193,736
Aker Christopher RaySr. VP & General Counsel10/01/20191,602
Hagan Joseph PPresident and CEO10/01/20195,969
Hagan Joseph PPresident and CEO08/15/20192,409
Aker Christopher RaySr. VP & General Counsel08/15/2019495
Hagan Joseph PPresident and CEO07/01/20197,584
Aker Christopher RaySr. VP & General Counsel07/01/20192,918
Chevallard Daniel R.Chief Financial Officer07/01/20193,500
PAPADOPOULOS STELIOSDirector05/07/2019400,000
RASTETTER WILLIAM HDirector05/07/2019100,320
Witz PascaleDirector05/07/201932,000
Hagan Joseph PPresident and CEO05/07/201935,850
Hagan Joseph PPresident and CEO05/16/201947,966
Chevallard Daniel R.Chief Financial Officer05/15/201914,089
Aker Christopher RaySr. VP & General Counsel05/15/20199,796
Walker Paul Edward10% Owner05/07/20191,227,640
Walker Paul EdwardDirector05/07/20191,227,640
Sonsini Peter W.10% Owner05/07/20191,227,640
SANDELL SCOTT D10% Owner05/07/20191,227,640
MOTT DAVID M10% Owner05/07/20191,227,640
MAKOWER JOSHUA10% Owner05/07/20191,227,640
Makhzoumi Mohamad10% Owner05/07/20191,227,640
Florence Anthony A. Jr.10% Owner05/07/20191,227,640
Chang Carmen10% Owner05/07/20191,227,640
Behbahani Ali10% Owner05/07/20191,227,640
BASKETT FOREST10% Owner05/07/20191,227,640
BARRIS PETER J10% Owner05/07/20191,227,640
Growth Equity Opportunities V, LLC10% Owner05/07/20191,227,640
Hagan Joseph PPresident and CEO05/07/201935,850
Witz PascaleDirector05/07/201932,000
RASTETTER WILLIAM HDirector05/07/2019100,320
PAPADOPOULOS STELIOSDirector05/07/2019400,000
Hagan Joseph PPresident and CEO04/01/20195,731
Aker Christopher RaySr. VP & General Counsel04/01/20192,659
Chevallard Daniel R.Chief Financial Officer04/01/20193,192
WRIGHT TIMOTHY MICHAELChief R & D Officer02/05/201938,000
Hagan Joseph PPresident and CEO02/05/201961,750
Chevallard Daniel R.Chief Financial Officer02/05/201928,500
PAPADOPOULOS STELIOSDirector12/28/201854,570
PAPADOPOULOS STELIOSDirector12/27/201827,460
PAPADOPOULOS STELIOSDirector12/26/201885,878
PAPADOPOULOS STELIOSDirector11/16/2018415,470
PAPADOPOULOS STELIOSDirector11/15/2018265,080
Collier Kathryn JDirector11/16/201810,011
Collier Kathryn JDirector06/05/20185,694
Collier Kathryn JDirector04/14/201838,550
BALTIMORE DAVIDDirector12/04/201754,000
FOLETTA MARK GDirector12/04/201764,000
PAPADOPOULOS STELIOSDirector12/04/201786,000
Rosen HughDirector12/04/201749,999
Witz PascaleDirector12/04/201754,000
RASTETTER WILLIAM HDirector12/04/201761,999
WRIGHT TIMOTHY MICHAELChief R & D Officer07/25/2017250,000
RASTETTER WILLIAM HDirector07/25/2017250,000
Hagan Joseph PPresident and CEO07/25/2017200,000
Chevallard Daniel R.Chief Financial Officer07/25/201750,000
PAPADOPOULOS STELIOSDirector07/25/2017910,000
PAPADOPOULOS STELIOSDirector03/22/2017368,100
PAPADOPOULOS STELIOSDirector03/21/2017239,800
RASTETTER WILLIAM HDirector03/07/2017287,500
Hagan Joseph PChief Operating Officer03/03/201671,900
ALNYLAM PHARMACEUTICALS, INC.10% Owner02/23/20167,180,000
FOLETTA MARK GDirector08/13/201576,405
PAPADOPOULOS STELIOSDirector08/07/201578,801
RASTETTER WILLIAM HDirector07/21/2015624,199
RASTETTER WILLIAM HDirector07/20/2015392,779
ISIS PHARMACEUTICALS INC10% Owner07/15/2015700,961
ISIS PHARMACEUTICALS INC10% Owner07/17/20151,133,754
ISIS PHARMACEUTICALS INC10% Owner07/16/20151,801,362
ISIS PHARMACEUTICALS INC10% Owner06/30/2015143,010
XANTHOPOULOS KLEANTHIS GPresident and CEO04/21/201522,800
XANTHOPOULOS KLEANTHIS GPresident and CEO04/20/201525,107
XANTHOPOULOS KLEANTHIS GPresident and CEO04/17/201528,093
XANTHOPOULOS KLEANTHIS GPresident and CEO04/21/20151,063,980
XANTHOPOULOS KLEANTHIS GPresident and CEO04/20/20151,113,514
XANTHOPOULOS KLEANTHIS GPresident and CEO04/17/20151,252,002
CARTER BRUCE L ADirector04/13/201595,600
CARTER BRUCE L ADirector04/13/2015353,164
XANTHOPOULOS KLEANTHIS GPresident and CEO03/05/201533,907
XANTHOPOULOS KLEANTHIS GPresident and CEO03/05/20151,808,063
XANTHOPOULOS KLEANTHIS GPresident and CEO02/27/201527
XANTHOPOULOS KLEANTHIS GPresident and CEO02/27/20151,365
XANTHOPOULOS KLEANTHIS GPresident and CEO02/02/2015912
XANTHOPOULOS KLEANTHIS GPresident and CEO01/30/20151,254
XANTHOPOULOS KLEANTHIS GPresident and CEO01/30/201564,351
XANTHOPOULOS KLEANTHIS GPresident and CEO02/02/201547,440
Gibson Neil WChief Scientific Officer01/28/20151,444,304
XANTHOPOULOS KLEANTHIS GPresident and CEO01/28/201532,300
XANTHOPOULOS KLEANTHIS GPresident and CEO01/29/201522,800
XANTHOPOULOS KLEANTHIS GPresident and CEO01/29/20151,082,634
XANTHOPOULOS KLEANTHIS GPresident and CEO01/28/20151,536,515
PAPADOPOULOS STELIOSDirector12/12/201457,000
Gibson Neil WChief Scientific Officer11/28/20144,350
Gibson Neil WChief Scientific Officer11/28/201448,245
ASTRAZENECA PLC10% Owner11/12/201434,000,000
ISIS PHARMACEUTICALS INC10% Owner11/03/201420,390,613
XANTHOPOULOS KLEANTHIS GPresident and CEO10/29/20141,332
XANTHOPOULOS KLEANTHIS GPresident and CEO10/29/201467,824
Gibson Neil WChief Scientific Officer10/29/20144,350
Gibson Neil WChief Scientific Officer10/29/201448,234
ISIS PHARMACEUTICALS INCDirector10/22/20141,533,135
ISIS PHARMACEUTICALS INCDirector10/24/201428,109
ISIS PHARMACEUTICALS INCDirector10/23/201424,202
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/24/201428,109
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/23/201424,202
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/22/20141,533,135
ISIS PHARMACEUTICALS INCDirector10/22/20141,533,126
ISIS PHARMACEUTICALS INCDirector10/24/201428,109
ISIS PHARMACEUTICALS INCDirector10/23/201424,202
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/24/201428,109
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/23/201424,202
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/22/20141,533,126
Gibson Neil WChief Scientific Officer10/22/20145,742
Gibson Neil WChief Scientific Officer10/22/201447,644
XANTHOPOULOS KLEANTHIS GPresident and CEO10/20/2014114
XANTHOPOULOS KLEANTHIS GPresident and CEO10/17/2014152
XANTHOPOULOS KLEANTHIS GPresident and CEO10/20/20142,100
XANTHOPOULOS KLEANTHIS GPresident and CEO10/17/20142,816
ISIS PHARMACEUTICALS INCDirector10/17/201420,371
ISIS PHARMACEUTICALS INCDirector10/16/201432,450
ISIS PHARMACEUTICALS INCDirector10/15/201428,687
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/17/201420,371
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/16/201432,450
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/15/201428,687
XANTHOPOULOS KLEANTHIS GPresident and CEO10/14/2014152
XANTHOPOULOS KLEANTHIS GPresident and CEO10/09/201440
XANTHOPOULOS KLEANTHIS GPresident and CEO10/14/20142,800
XANTHOPOULOS KLEANTHIS GPresident and CEO10/09/2014735
ISIS PHARMACEUTICALS INCDirector10/10/201412,813
ISIS PHARMACEUTICALS INCDirector10/09/201431,238
ISIS PHARMACEUTICALS INCDirector10/08/201421,888
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/10/201412,813
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/09/201431,238
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/08/201421,888
ISIS PHARMACEUTICALS INCDirector10/03/201422,688
ISIS PHARMACEUTICALS INCDirector10/02/201424,903
ISIS PHARMACEUTICALS INCDirector10/01/201421,808
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/03/201422,688
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/02/201424,903
ALNYLAM PHARMACEUTICALS, INC.10% Owner10/01/201421,808
XANTHOPOULOS KLEANTHIS GPresident and CEO09/30/2014874
XANTHOPOULOS KLEANTHIS GPresident and CEO09/30/201416,137
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/25/201417,790
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/24/201426,978
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/26/201417,598
ISIS PHARMACEUTICALS INCDirector09/26/201417,598
ISIS PHARMACEUTICALS INCDirector09/25/201417,790
ISIS PHARMACEUTICALS INCDirector09/24/201426,978
ISIS PHARMACEUTICALS INCDirector09/18/201411,098
ISIS PHARMACEUTICALS INCDirector09/17/201415,610
ISIS PHARMACEUTICALS INCDirector09/19/201429,587
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/19/201429,587
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/18/201411,098
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/17/201415,610
Gibson Neil WChief Scientific Officer09/12/20143,828
Gibson Neil WChief Scientific Officer09/11/20143,480
Gibson Neil WChief Scientific Officer09/11/201416,010
Gibson Neil WChief Scientific Officer09/12/201417,616
ISIS PHARMACEUTICALS INCDirector09/12/201427,861
ISIS PHARMACEUTICALS INCDirector09/11/201426,636
ISIS PHARMACEUTICALS INCDirector09/10/201415,399
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/12/201427,861
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/11/201426,636
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/10/201415,399
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/04/201442,656
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/03/201411,471
ALNYLAM PHARMACEUTICALS, INC.10% Owner09/05/201416,974
ISIS PHARMACEUTICALS INCDirector09/05/201416,974
ISIS PHARMACEUTICALS INCDirector09/04/201442,656
ISIS PHARMACEUTICALS INCDirector09/03/201411,471
ISIS PHARMACEUTICALS INCDirector08/29/201410,254
ISIS PHARMACEUTICALS INCDirector08/28/201413,921
ISIS PHARMACEUTICALS INCDirector08/27/201410,821
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/28/201413,921
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/27/201410,821
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/29/201410,254
XANTHOPOULOS KLEANTHIS GPresident & CEO08/28/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO08/28/201424,754
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/20/201421,424
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/22/201435,443
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/21/201417,222
ISIS PHARMACEUTICALS INCDirector08/22/201435,443
ISIS PHARMACEUTICALS INCDirector08/21/201417,222
ISIS PHARMACEUTICALS INCDirector08/20/201421,424
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/15/201410,115
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/14/201412,324
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/13/201415,788
ISIS PHARMACEUTICALS INCDirector08/15/201410,115
ISIS PHARMACEUTICALS INCDirector08/14/201412,324
ISIS PHARMACEUTICALS INCDirector08/13/201415,788
ISIS PHARMACEUTICALS INCDirector08/08/201412,583
ISIS PHARMACEUTICALS INCDirector08/07/201417,322
ISIS PHARMACEUTICALS INCDirector08/06/201422,300
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/08/201412,583
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/07/201417,322
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/06/201422,300
XANTHOPOULOS KLEANTHIS GPresident & CEO08/05/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO08/05/201424,739
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/30/20146,602
ALNYLAM PHARMACEUTICALS, INC.10% Owner08/01/201416,153
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/31/201411,235
ISIS PHARMACEUTICALS INCDirector08/01/201416,153
ISIS PHARMACEUTICALS INCDirector07/31/201411,235
ISIS PHARMACEUTICALS INCDirector07/30/20146,602
ISIS PHARMACEUTICALS INCDirector07/25/201411,137
ISIS PHARMACEUTICALS INCDirector07/24/201412,598
ISIS PHARMACEUTICALS INCDirector07/23/201411,702
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/23/201411,702
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/25/201411,137
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/24/201412,598
ISIS PHARMACEUTICALS INCDirector07/16/201423,058
ISIS PHARMACEUTICALS INCDirector07/18/201434,001
ISIS PHARMACEUTICALS INCDirector07/17/201432,906
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/18/201434,001
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/17/201432,906
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/16/201423,058
ISIS PHARMACEUTICALS INCDirector07/11/201411,339
ISIS PHARMACEUTICALS INCDirector07/10/201430,109
ISIS PHARMACEUTICALS INCDirector07/09/201412,748
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/11/201411,339
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/10/201430,109
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/09/201412,748
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/03/20149,678
ALNYLAM PHARMACEUTICALS, INC.10% Owner07/02/201425,011
ISIS PHARMACEUTICALS INC10% Owner07/03/20149,678
ISIS PHARMACEUTICALS INC10% Owner07/02/201425,011
Gibson Neil WChief Scientific Officer07/01/20144,350
Gibson Neil WChief Scientific Officer07/01/201420,260
XANTHOPOULOS KLEANTHIS GPresident & CEO07/01/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO07/01/201428,426
ISIS PHARMACEUTICALS INC10% Owner06/27/201424,931
ISIS PHARMACEUTICALS INC10% Owner06/26/201413,408
ISIS PHARMACEUTICALS INC10% Owner06/25/201421,566
ALNYLAM PHARMACEUTICALS, INC.10% Owner06/25/201421,566
ALNYLAM PHARMACEUTICALS, INC.10% Owner06/27/201424,931
ALNYLAM PHARMACEUTICALS, INC.10% Owner06/26/201413,408
Gibson Neil WChief Scientific Officer06/17/20148,700
Gibson Neil WChief Scientific Officer06/17/201440,227
XANTHOPOULOS KLEANTHIS GPresident & CEO06/09/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO06/09/201425,017
XANTHOPOULOS KLEANTHIS GPresident & CEO05/28/2014332
XANTHOPOULOS KLEANTHIS GPresident & CEO05/27/2014662
XANTHOPOULOS KLEANTHIS GPresident & CEO05/29/2014337
XANTHOPOULOS KLEANTHIS GPresident & CEO05/28/20146,126
XANTHOPOULOS KLEANTHIS GPresident & CEO05/27/201412,203
XANTHOPOULOS KLEANTHIS GPresident & CEO05/29/20146,209
Gibson Neil WChief Scientific Officer04/09/20144,350
Gibson Neil WChief Scientific Officer04/09/201420,271
XANTHOPOULOS KLEANTHIS GPresident & CEO03/06/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO03/06/201426,623
XANTHOPOULOS KLEANTHIS GPresident & CEO03/06/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO03/06/201439,778
Gibson Neil WChief Scientific Officer03/06/20144,350
Gibson Neil WChief Scientific Officer03/06/201428,428
XANTHOPOULOS KLEANTHIS GPresident & CEO02/05/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO02/05/201429,437
Gibson Neil WChief Scientific Officer02/06/201478,300
Gibson Neil WChief Scientific Officer02/05/20144,350
Gibson Neil WChief Scientific Officer02/05/2014146,706
Sanofi10% Owner02/04/20149,999,993
Gibson Neil WChief Scientific Officer01/21/201411,760
Gibson Neil WChief Scientific Officer01/21/201435,764
Gibson Neil WChief Scientific Officer01/17/20149,706
Gibson Neil WChief Scientific Officer01/17/201436,494
Gibson Neil WChief Scientific Officer01/16/20141,914
Gibson Neil WChief Scientific Officer01/16/20148,837
XANTHOPOULOS KLEANTHIS GPresident & CEO01/02/20141,332
XANTHOPOULOS KLEANTHIS GPresident & CEO01/02/201425,408
Gibson Neil WChief Scientific Officer02/04/201387,000
ISIS PHARMACEUTICALS INC10% Owner10/10/20123,000,000
PARSHALL B LYNNEDirector10/10/20123,000,000
CROOKE STANLEY TDirector10/10/20123,000,000
Load More Insider Transactions
FUNDS WITH A POSITION IN REGULUS THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
VIVO CAPITAL, LLC5,000,0001.13%NewOther
GEODE CAPITAL MANAGEMENT, LLC122,5210.00002%No changeOther
RENAISSANCE TECHNOLOGIES LLC54,6000.00011%8.98%Other
BLACKROCK INC.5730%-7.28%Other
CHANGE IN SHARES OUTSTANDING FOR REGULUS THERAPEUTICS INC
STOCK BUYBACKS FOR REGULUS THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
3.09%
1Q
12/31/2023
06/30/2023
5.94%
2Q
12/31/2023
03/31/2023
20.14%
3Q
12/31/2023
12/31/2022
20.04%
4Q
12/31/2023
09/30/2022
35.18%
5Q
12/31/2023
06/30/2022
38.49%
6Q
12/31/2023
03/31/2022
38.63%
7Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
3.09%
1Q
06/30/2023
5.94%
2Q
03/31/2023
20.14%
3Q
12/31/2022
20.04%
4Q
09/30/2022
35.18%
5Q
06/30/2022
38.49%
6Q
03/31/2022
38.63%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR REGULUS THERAPEUTICS INC
LOADING...